243 related articles for article (PubMed ID: 29848909)
21. Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance.
Papp C; Kocsis K; Tóth R; Bodai L; Willis JR; Ksiezopolska E; Lozoya-Pérez NE; Vágvölgyi C; Mora Montes H; Gabaldón T; Nosanchuk JD; Gácser A
mSphere; 2018 Nov; 3(6):. PubMed ID: 30429225
[No Abstract] [Full Text] [Related]
22. A comparative evaluation of properties and clinical efficacy of the echinocandins.
Kim R; Khachikian D; Reboli AC
Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730
[TBL] [Abstract][Full Text] [Related]
23. The echinocandins: three useful choices or three too many?
Bal AM
Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413
[TBL] [Abstract][Full Text] [Related]
24. Reshaping Echinocandin Antifungal Drugs To Circumvent Glucan Synthase Point-Mutation-Mediated Resistance.
Jospe-Kaufman M; Ben-Zeev E; Mottola A; Dukhovny A; Berman J; Carmeli S; Fridman M
Angew Chem Int Ed Engl; 2024 Feb; 63(9):e202314728. PubMed ID: 38161189
[TBL] [Abstract][Full Text] [Related]
25. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
[TBL] [Abstract][Full Text] [Related]
26. Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent.
Staab JF; Kahn JN; Marr KA
Antimicrob Agents Chemother; 2010 Dec; 54(12):4992-8. PubMed ID: 20855747
[TBL] [Abstract][Full Text] [Related]
27. Enfumafungin derivative MK-3118 shows increased in vitro potency against clinical echinocandin-resistant Candida Species and Aspergillus species isolates.
Jiménez-Ortigosa C; Paderu P; Motyl MR; Perlin DS
Antimicrob Agents Chemother; 2014; 58(2):1248-51. PubMed ID: 24323472
[TBL] [Abstract][Full Text] [Related]
28.
Jiménez-Ortigosa C; Perez WB; Angulo D; Borroto-Esoda K; Perlin DS
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630180
[TBL] [Abstract][Full Text] [Related]
29. Echinocandins: the newest class of antifungals.
Sucher AJ; Chahine EB; Balcer HE
Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
[TBL] [Abstract][Full Text] [Related]
30. A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus.
Rocha EM; Garcia-Effron G; Park S; Perlin DS
Antimicrob Agents Chemother; 2007 Nov; 51(11):4174-6. PubMed ID: 17724146
[TBL] [Abstract][Full Text] [Related]
31. Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase.
Kahn JN; Garcia-Effron G; Hsu MJ; Park S; Marr KA; Perlin DS
Antimicrob Agents Chemother; 2007 May; 51(5):1876-8. PubMed ID: 17325225
[TBL] [Abstract][Full Text] [Related]
32. Clinical perspectives on echinocandin resistance among Candida species.
Shields RK; Nguyen MH; Clancy CJ
Curr Opin Infect Dis; 2015 Dec; 28(6):514-22. PubMed ID: 26524326
[TBL] [Abstract][Full Text] [Related]
33. Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.
Niimi K; Monk BC; Hirai A; Hatakenaka K; Umeyama T; Lamping E; Maki K; Tanabe K; Kamimura T; Ikeda F; Uehara Y; Kano R; Hasegawa A; Cannon RD; Niimi M
J Antimicrob Chemother; 2010 May; 65(5):842-52. PubMed ID: 20233776
[TBL] [Abstract][Full Text] [Related]
34. Emergence of Echinocandin Resistance Due to a Point Mutation in the
Jiménez-Ortigosa C; Moore C; Denning DW; Perlin DS
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923871
[TBL] [Abstract][Full Text] [Related]
35. Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression.
Niimi K; Woods MA; Maki K; Nakayama H; Hatakenaka K; Chibana H; Ikeda F; Ueno K; Niimi M; Cannon RD; Monk BC
J Antimicrob Chemother; 2012 Jul; 67(7):1666-76. PubMed ID: 22514266
[TBL] [Abstract][Full Text] [Related]
36. Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the
Cheung YY; Hui M
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827418
[TBL] [Abstract][Full Text] [Related]
37. Biofilms and beyond: expanding echinocandin utility.
Larkin EL; Dharmaiah S; Ghannoum MA
J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i73-i81. PubMed ID: 29304214
[TBL] [Abstract][Full Text] [Related]
38. Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.
Thompson GR; Wiederhold NP; Vallor AC; Villareal NC; Lewis JS; Patterson TF
Antimicrob Agents Chemother; 2008 Oct; 52(10):3783-5. PubMed ID: 18676885
[TBL] [Abstract][Full Text] [Related]
39.
Suwunnakorn S; Wakabayashi H; Kordalewska M; Perlin DS; Rustchenko E
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358288
[No Abstract] [Full Text] [Related]
40. Candida lusitaniae MICs to the echinocandins are elevated but FKS-mediated resistance is rare.
Lockhart SR; Pham CD; Kuykendall RJ; Bolden CB; Cleveland AA
Diagn Microbiol Infect Dis; 2016 Jan; 84(1):52-54. PubMed ID: 26429293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
